Both the U.S. and the European Union are funding massive, multi-year brain-mapping initiatives that will require the development of new technologies to measure, map and analyze brain activity.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||